India's drug regulator tightens medicine label scrutiny. The CDSCO is stepping up inspections to ensure critical information like medicine names, expiry dates, and batch numbers are clearly visible and properly placed on pharmaceutical packaging. This regulatory push aims to reduce medication errors and enhance patient safety across India's $50 billion pharmaceuticals market. The move follows consumer complaints about illegible labels and poorly positioned information. A committee has recommended that inspectors focus on label visibility, durability, and placement during routine plant inspections. Manufacturers are being encouraged to voluntarily adopt improved packaging practices to enhance readability without rigid technical specifications. The initiative targets standardization across the industry to prevent confusion between generic and branded medicines.
Post from MarketNews_en
Log in to interact with content.